Alliance for Public Health in collaboration with 11 partner organizations in Eastern Europe and Central Asia (EECA) presents the report “Hepatitis B and C in Eastern Europe and Central Asia: response to the epidemics”.
The purpose of this report is to provide an overview of key aspects of the hepatitis B (HBV) and C (HCV) epidemics and response in 11 EECA countries (Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Russia, Tajikistan, Ukraine and Uzbekistan).
It also includes tools and activities for civil society organizations (CSOs) and community-based groups working on expanding access to treatment of viral hepatitis in the region. Right now, there is a strong global movement towards elimination of the viral hepatitis hepatitis It is essential that this analysis is available to ensure that the EECA region is not left out of global strategies being developed to provide universal access to innovative curative treatment regimens currently in the pipeline.
The overview summarizes data with scesial focus on availability of HCV medicines, HCV treatment guidelines, national/donor HCV treatment programs, and civil society involvement in the HCV response. It also offers possible approaches and steps that could be taken by CSOs to improve access to HCV treatment in their countries.
You may find the updated report here